-+ 0.00%
-+ 0.00%
-+ 0.00%

LONGEVERON® RESULTS OF PHASE 2B CLINICAL TRIAL DEMONSTRATING STEM CELL THERAPY IMPROVED CONDITION OF PATIENTS WITH AGE-RELATED FRAILTY PUBLISHED IN CELL STEM CELL

Reuters·02/25/2026 16:05:00

Please log in to view news